VIRGINIA RETIREMENT SYSTEMS ET AL - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
VIRGINIA RETIREMENT SYSTEMS ET AL ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2020$352,000
-13.1%
124,7000.0%0.01%
+25.0%
Q4 2019$405,000
+50.6%
124,7000.0%0.00%
+33.3%
Q3 2019$269,000
-31.4%
124,7000.0%0.00%
-40.0%
Q2 2019$392,000
-8.8%
124,700
+7.8%
0.01%0.0%
Q1 2019$430,000
+1333.3%
115,700
+1034.3%
0.01%
Q4 2018$30,000
-43.4%
10,200
-49.0%
0.00%
-100.0%
Q3 2018$53,000
-47.0%
20,000
-53.1%
0.00%0.0%
Q2 2018$100,000
-20.0%
42,6000.0%0.00%
-50.0%
Q1 2018$125,000
+6.8%
42,6000.0%0.00%
+100.0%
Q4 2017$117,000
-27.3%
42,600
-10.3%
0.00%
-50.0%
Q3 2017$161,000
+24.8%
47,500
-9.4%
0.00%0.0%
Q2 2017$129,000
+8.4%
52,4000.0%0.00%0.0%
Q1 2017$119,000
+7.2%
52,4000.0%0.00%0.0%
Q4 2016$111,000
-36.9%
52,4000.0%0.00%
-33.3%
Q3 2016$176,000
+6.7%
52,4000.0%0.00%
+50.0%
Q2 2016$165,000
-10.8%
52,4000.0%0.00%
-33.3%
Q4 2015$185,000
-29.9%
52,4000.0%0.00%
-25.0%
Q3 2015$264,000
-21.7%
52,4000.0%0.00%
-20.0%
Q2 2015$337,000
-8.7%
52,4000.0%0.01%
-16.7%
Q1 2015$369,000
-8.7%
52,4000.0%0.01%0.0%
Q4 2014$404,000
+3.3%
52,4000.0%0.01%0.0%
Q3 2014$391,000
-22.3%
52,400
+0.8%
0.01%
-33.3%
Q2 2014$503,000
+150.2%
52,000
+114.9%
0.01%
+125.0%
Q1 2014$201,000
-1.5%
24,2000.0%0.00%0.0%
Q4 2013$204,000
+5.7%
24,2000.0%0.00%0.0%
Q3 2013$193,000
+3.2%
24,2000.0%0.00%0.0%
Q2 2013$187,00024,2000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2018
NameSharesValueWeighting ↓
SMH CAPITAL ADVISORS INC 81,713$176,0000.39%
BRANDES INVESTMENT PARTNERS, LP 5,465,156$11,805,0000.30%
Crestline Management, LP 875,000$1,890,0000.30%
West Family Investments, Inc. 539,450$1,165,0000.29%
WEBER ALAN W 200,000$432,000,0000.19%
Zebra Capital Management LLC 73,910$160,0000.18%
RBF Capital, LLC 569,323$1,230,0000.14%
Leap Investments LP 69,496$150,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 4,387,038$9,476,0000.06%
CHICAGO EQUITY PARTNERS LLC 519,315$1,122,0000.05%
View complete list of PDL BIOPHARMA INC shareholders